Advanced glycation end-products: a review
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Advanced glycation end-products are a complex and heterogeneous group of compounds that have been implicated in diabetes related complications. At present it is not known if they are the cause or the consequence of the complications observed. We discuss the chemistry of advanced glycated end-product formation and their patho-biochemistry particularly in relation to the diabetic microvascular complications of retinopathy, neuropathy and nephropathy as well as their role in the accelerated vasculopathy observed in diabetes. The concept of carbonyl stress as a cause for advanced glycated end-product toxicity is mentioned. We discuss alterations in the concentrations of advanced glycated end-products in the body, particularly in relation to changes occurring with age, diabetes and its complications such as nephropathy. Problems relating to current methods of advanced glycated end-product detection and measurement are highlighted including the lack of a universally established method of detection or unit of measurement. Agents used for the treatment of advanced glycated end-product accumulation are reviewed, with an emphasis on the results of the recent phase III trials using aminoguanidine and diabetes related complications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“About 20 various AGEs have been detected in blood and tissues, as well as in foods.”
From Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging (2023) · cites this paper as Singh et al. 2001
In the citing paper
“The most abundant non-fluorescence AGEs involve carboxymethyl-lysine (CML), and carboxyethyl-lysine (CEL). Fluorescence AGEs involve methylglyoxal-lysine and pentosidine (Singh et al. 2001).”
From Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging (2023) · cites this paper as Singh et al. 2001
In the citing paper
“The Maillard reaction generates these highly reactive dicarbonyls, also referred to as 𝛼-oxoaldehydes, which in addition to methylglyoxal include glyoxal and 3deoxyglucosone. [17]”
From The Role of Dietary Advanced Glycation End Products in Metabolic Dysfunction (2021) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630
Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.
Baynes, J. W., & Thorpe, S. R. (1999) · Diabetes · doi:10.2337/diabetes.48.1.1 · Cited by 2,441
Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases
Taguchi, A., Blood, D. C., del Toro, G., Canet, A., Lee, D. C., Qu, W., Tanji, N., Lu, Y., Lalla, E., Fu, C., et al. (2000) · Nature · doi:10.1038/35012626 · Cited by 1,217
Koschinsky, T., He, C.-J., Mitsuhashi, T., Bucala, R., Liu, C., Buenting, C., Heitmann, K., & Vlassara, H. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6474 · Cited by 792
Tobacco smoke is a source of toxic reactive glycation products
Cerami, C., Founds, H., Nicholl, I., Mitsuhashi, T., Giordano, D., Vanpatten, S., Lee, A., Al-Abed, Y., Vlassara, H., Bucala, R., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13915 · Cited by 549
McCance, D. R., Dyer, D. G., Dunn, J. A., Bailie, K. E., Thorpe, S. R., Baynes, J. W., & Lyons, T. J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116482 · Cited by 444
Role of the Maillard Reaction in Aging of Tissue Proteins
Frye, E. B., Degenhardt, T. P., Thorpe, S. R., & Baynes, J. W. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.30.18714 · Cited by 366
Giardino, I., Edelstein, D., & Brownlee, M. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117296 · Cited by 364
Glycation impairs high-density lipoprotein function
Hedrick, C. C., Thorpe, S. R., Fu, M.-X., Harper, C. M., Yoo, J., Kim, S.-M., Wong, H., & Peters, A. L. (2000) · Diabetologia · doi:10.1007/s001250050049 · Cited by 310
Research works printed but not linked: 2
- Kennedy L (1992) Glycation of immunoglobulins and serum proteins. In: Alberti KGMM, de Fronzo RA, Keen H, Zimmet P (eds) International Textbook of Dia- betes Mellitus, 2nd edn. John Wiley, Chichester pp 985±1007
- Neumann A, Schinzel R, Palm D, Riederer P, Munch G (1999) High molecular weight hyaluronic acid inhibits advanced glycation end-product induced NF-kappaB acti- vation and cytokine expression. FEBS Letters 453: 283±287
Cited by
Items 501–600 of 1,005
Zhang, F., Kent, K. C., Yamanouchi, D., Zhang, Y., Kato, K., Tsai, S., Nowygrod, R., Schmidt, A. M., & Liu, B. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e3181b41a18 · Cited by 70
“Advanced glycation end products (AGEs) are formed from proteins and peptides by nonenzymatic glycoxidation after contact with aldose sugars.(9,10) AGE as well as its receptor (RAGE) has been implicated in disease of the elderly age including atherosclerosis and Alzheimer.”
BackgroundJiao, L., Taylor, P. R., Weinstein, S. J., Graubard, B. I., Virtamo, J., Albanes, D., & Stolzenberg-Solomon, R. Z. (2011) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0066 · Cited by 70
“AGEs are a group of irreversible adducts or crosslinking created through a nonenzymatic glycosylation between reducing sugars and free amino groups of proteins, lipids, or nucleic acids (1).”
Hiền, T. T., Turczyńska, K. M., Dahan, D., Ekman, M., Grossi, M., Sjögren, J. L., Nilsson, J., Braun, T. W., Boettger, T., Garcia‐Vaz, E., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.654384 · Cited by 75
“These glycated and oxidized lipids and proteins can be formed both intra-and extra-cellularly and interact with AGE receptors (RAGE) (Reviewed by (75)).”
Pharmacotherapy for diabetic retinopathy
Comer, G. M., & Ciulla, T. A. (2004) · Current Opinion in Ophthalmology · doi:10.1097/01.icu.0000143685.60479.3b · Cited by 71
Choi, K. M., Lee, K. W., Seo, J. A., Oh, J. H., Kim, S. G., Kim, N. H., Choi, D. S., & Baik, S. H. (2004) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2004.02.014 · Cited by 75
Tanaka, K.-I., Yamaguchi, T., Kaji, H., Kanazawa, I., & Sugimoto, T. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.07.126 · Cited by 72
Alagebrium and Complications of Diabetes Mellitus
Toprak, Ç., & Yiğitaslan, S. (2019) · Eurasian Journal of Medicine · doi:10.5152/eurasianjmed.2019.18434 · Cited by 75
“AGEs contribute to the aging process because most of their primary effects are seen on long-lasting proteins such as collagen and lens crystals [1, 2].”
BackgroundAdvanced glycation end products (AGEs) activate mast cells
Sick, É., Brehin, S., André, P., Coupin, G., Landry, Y., Takeda, K., & Gies, J. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00905.x · Cited by 73
“Reducing sugars such as glucose, react non-enzymatically with amino groups of proteins, lipids and nucleic acids to produce AGEs via the Maillard reaction that involves a series of reactions forming Schiff bases and Amadori products (Singh et al., 2001).”
BackgroundAdvanced glycation end-products and insulin signaling in granulosa cells
Diamanti‐Kandarakis, E., Chatzigeorgiou, A., Papageorgiou, E. G., Koundouras, D., & Koutsilieris, M. (2015) · Experimental Biology and Medicine · doi:10.1177/1535370215584937 · Cited by 70
“Advanced glycation end-products (AGEs) present a group of heterogeneous compounds of high reactivity with increased cross-linking potential and detrimental effects over normal tissue physiology.(1,2) They are formed from non-enzymatic reaction of reducing sugars with the amino groups of proteins, nucleic acids, and li…”
BackgroundNotsu, M., Yamaguchi, T., Okazaki, K., Tanaka, K.-I., Ogawa, N., Kanazawa, I., & Sugimoto, T. (2014) · Endocrinology · doi:10.1210/en.2013-1818 · Cited by 75
The regulation of EN-RAGE (S100A12) gene expression in human THP-1 macrophages
Hasegawa, T., Kosaki, A., Kimura, T., Matsubara, H., Mori, Y., Okigaki, M., Masaki, H., Toyoda, N., Inoue-Shibata, M., Kimura, Y., et al. (2003) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.08.021 · Cited by 75
“Engagement of RAGE by AGEs results in activation of p21ras, which feeds into ERK1/2 and p38 mitogen-activated protein (MAP) kinase pathway and activates nuclear factor- B (NF- B) in vascular endothelial cells, smooth muscle cells and monocytes [2–5].”
BackgroundNiu, Y., Xie, T., Ge, K., Lin, Y., & Lu, S. (2008) · American Journal of Dermatopathology · doi:10.1097/dad.0b013e31816a8c5b · Cited by 73
Diabetic retinopathy: Pathogenic mechanisms and current treatments
Chistiakov, D. A. (2011) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2012.02.025 · Cited by 78
“In addition, binding of AGEs to specific cell surface AGE receptors such as the receptor for advanced glycation end product (RAGE) can induce intracellular signaling, oxidative stress, and production of key pro-inflammatory and pro-sclerotic cytokines [41].”
BackgroundInfluentialJiao, L., Weinstein, S. J., Albanes, D., Taylor, P. R., Graubard, B. I., Virtamo, J. R. K., & Stolzenberg‐Solomon, R. Z. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2573 · Cited by 74
Importance of the Nucleophilic Property of Tea Polyphenols
Meng, Q. X., Li, S., Huang, J., Wei, C., Wan, X., Sang, S., & Ho, C. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b05917 · Cited by 71
Ravichandran, G., Lakshmanan, D. K., Raju, K., Elangovan, A., Nambirajan, G., Devanesan, A. A., & Thilagar, S. (2019) · Environment International · doi:10.1016/j.envint.2018.12.032 · Cited by 76
Cao, X., Xia, Y., Zeng, M., Wang, W., He, Y., & Liu, J. (2019) · Chemistry & Biodiversity · doi:10.1002/cbdv.201900174 · Cited by 70
“[1] AGEs exist in different tissues of the body, such as renal cortex, liver, mesangium, lung and so on, especially in diabetes patients.[2] In addition, the formation of AGEs is associated with many factors, including different food ingredients, storage methods and processing methods, therefore, dietary intake is a m…”
BackgroundYu, X., Ma, X., Lin, W., Xu, Q., Zhou, H., & Kuang, H. (2020) · Experimental Eye Research · doi:10.1016/j.exer.2020.108300 · Cited by 70
Diabetic neuropathies: components of etiology
Tomlinson, D. R., & Gardiner, N. J. (2008) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2008.00167.x · Cited by 81
“The RAGE ligand, carboxymethyllysine has recently been shown to activate nuclear factor kB (NFkB) signaling in neurons (Haslbeck et al., 2007).”
BackgroundActive vitamin D possesses beneficial effects on the interaction between muscle and bone
Tanaka, K.-I., Kanazawa, I., Yamaguchi, T., Yano, S., Kaji, H., & Sugimoto, T. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.05.145 · Cited by 73
Coumarin derivatives: an updated patent review (2012 – 2014)
Katsori, A., & Hadjipavlou‐Litina, D. (2014) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2014.972368 · Cited by 74
“Thus, formation and accumulation of AGEs lead in a various types of AGEs-related disorders such as diabetic vascular complications, neurodegenerative diseases and cancer [70-73].”
BackgroundDiamanti-Kandarakis, E., Piouka, A., Livadas, S., Piperi, C., Katsikis, I., Papavassiliou, A. G., & Panidis, D. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-0510 · Cited by 66
Palma-Duran, S. A., Vlassopoulos, A., Lean, M., Govan, L., & Combet, E. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2014.973932 · Cited by 66
“Glycohaemoglobin (HbA1c) is an early glycation product and a marker of chronic glycaemia from the preceding 2 to 3 months (Singh et al., 2001; Diagnosis and classification of diabetes mellitus 2012).”
BackgroundOtero, K., MARTÍNEZ, F., Beltrán, A. E., González, D., HERRERA, B., Quintero, G., Delgado, R., & Armando Rojas, R. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3590567 · Cited by 69
How to treat erectile dysfunction in men with diabetes: from pathophysiology to treatment
Hatzimouratidis, K., & Hatzichristou, D. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0545-6 · Cited by 68
UFRGS-UNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL
Saúde, B. D., & Pós-Graduação, P. R. D. (2009) · Cited by 68
Glucose-derived AGEs enhance human gastric cancer metastasis through RAGE/ERK/Sp1/MMP2 cascade
Deng, R., Mo, F., Chang, B., Zhang, Q., Ran, H., Yang, S., Zhu, Z., Hu, L., & Su, Q. (2017) · Oncotarget · doi:10.18632/oncotarget.22185 · Cited by 69
“A lot of factors include hyperglycemia, age, smoking, and inflammation will accelerate the formation and accumulation of advanced glycation end products in vivo [2].”
BackgroundAssessment of Advanced Glycation End Products and Receptors and the Risk of Dementia
Chen, J., Mooldijk, S. S., Licher, S., Waqas, K., Ikram, M. K., Uitterlinden, A. G., Zillikens, M., & Ikram, M. A. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.33012 · Cited by 72
Zheng, B., Meng, J., Zhu, Y., Ding, M., Zhang, Y., & Zhou, J. (2021) · Journal of Ovarian Research · doi:10.1186/s13048-021-00912-y · Cited by 71
“However, study showed that mitochondrial membrane potential is a universal selective indicator of mitochondrial function, and is essential for mitochondrial ability to maintain a balanced metabolic micro-environment [9], indicating that mitochondrial membrane Open Access”
BackgroundRole of Oxidative Stress in the Pathogenesis of Atherothrombotic Diseases
Petrucci, G., Rizzi, A., Hatem, D., Tosti, G., Rocca, B., & Pitocco, D. (2022) · Antioxidants · doi:10.3390/antiox11071408 · Cited by 71
“which is measurable in organic fluids and tissues [173].”
BackgroundChen, M., Meng, X., Han, Y.-P., Yan, J.-L., Xiao, C., & Qian, L.-B. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.983713 · Cited by 82
“Under long-standing hyperglycemia, reducing sugars such as glucose and fructose nonenzymatically binds with amino-acid residues in proteins, lipids and nucleic acids to form Schiff bases and Amadori products, the so-called Maillard reaction (Figure 2B), resulting in the accumulation of AGEs (30).”
BackgroundInfluentialCardiovascular protective effect of polysaccharide from Ophiopogon japonicus in diabetic rats
Zhang, J., Fan, S., Mao, Y., Ji, Y., Jin, L., Lü, J., & Chen, X. (2015) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2015.09.069 · Cited by 68
Chen, P., Zhao, J., & Gregersen, H. N. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1951-0 · Cited by 70
Kazeem, M. I., Akanji, M., Hafizur, R. M., & Choudhary, M. I. (2012) · Asian Pacific Journal of Tropical Biomedicine · doi:10.1016/s2221-1691(12)60218-4 · Cited by 68
Canagliflozin Prevents Diabetes-Induced Vascular Dysfunction in ApoE-Deficient Mice
Rahadian, A., Fukuda, D., Salim, H. M., Yagi, S., Kusunose, K., Yamada, H., Soeki, T., & Sata, M. (2020) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.52100 · Cited by 63
15 th Golgi lecture: from hyperglycaemia to the dysregulation of vascular remodelling in diabetes
Mario, U. D., & Pugliese, G. (2001) · Diabetologia · doi:10.1007/s001250051676 · Cited by 68
Yugar‐Toledo, J. C., Tanus-Santos, J. E., Sabha, M., de Sousa, M. G., Cittadino, M., Tácito, L. H. B., & Moreno, H. (2004) · CHEST Journal · doi:10.1378/chest.125.3.823 · Cited by 73
Mamputu, J., & Renier, G. (2002) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(01)00229-x · Cited by 78
“Considerable evidence now supports a major role for AGEs in the development of diabetic retinopathy (Chibber et al., 1997; Hammes et al., 1991, 1999; Singh et al., 2001; Stitt, 2001; Stitt et al., 1998).”
BackgroundSaitta, E. T., Liang, R., Lau, M. C., Brown, C. M., Longrich, N. R., Kaye, T. G., Novak, B. J., Salzberg, S. L., Norell, M. A., Abbott, G. D., et al. (2019) · eLife · doi:10.7554/elife.46205 · Cited by 67
“either ancient or more recent infiltrating microbes), and the presence of any amide bands in Raman spectra is likely insufficient evidence for endogenous oligopeptide preservation (see a similar discussion of amide bands in FTIR below) especially in association with polymers that form as a result of protein degradatio…”
BackgroundAdvanced Glycation End Products: A Comprehensive Review of Their Detection and Occurrence in Food
Li, L., Zhuang, Y., Zou, X., Chen, M., Cui, B., Ye, J., & Cheng, Y. (2023) · Foods · doi:10.3390/foods12112103 · Cited by 74
“A category of hazardous chemically stable substances known as advanced glycation end products (AGEs), formed in the last step of the MR, have complicated structures [3].”
Ferchichi, L., Derbré, S., Mahmood, K., Touré, K., Guilet, D., Litaudon, M., Awang, K., Hadi, A. H. A., Ray, A. L., & Richomme, P. (2012) · Phytochemistry · doi:10.1016/j.phytochem.2012.02.006 · Cited by 68
“Advanced glycation end-products (AGEs) are involved in the pathogenesis of diabetes (Brownlee, 2001; Singh et al., 2001) and neurological diseases such as the Alzheimer’s disease (Takeuchi and Yamagishi, 2008).”
BackgroundThe Novel Function of Advanced Glycation End Products in Regulation of MMP-9 Production
Zhang, F., Banker, G., Liu, X., Suwanabol, P. A., Lengfeld, J. E., Yamanouchi, D., Kent, K. C., & Liu, B. (2010) · Journal of Surgical Research · doi:10.1016/j.jss.2010.04.027 · Cited by 73
“Since AGEs are a group of compounds with heterogenous and homogenous structures, there is currently no universally established method to measure AGE concentrations in patients [38].”
BackgroundMali, V. R., Ning, R., Chen, J., Yang, X.-P., Xu, J., & Palaniyandi, S. S. (2014) · Experimental Biology and Medicine · doi:10.1177/1535370213520109 · Cited by 65
“Hyperglycemia leads to production of reactive oxygen species (ROS), which results in formation of advanced glycated-end products (AGE).(1) AGE-induced microvascular and macrovascular complications of diabetes mellitus (DM) are very well documented in experimental and clinical studies.”
BackgroundThe Impact of Microbiota-Gut-Brain Axis on Diabetic Cognition Impairment
Xu, Y., Zhou, H., & Zhu, Q. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00106 · Cited by 66
“AGEs are a broad class of non-enzymatic products of reactions between proteins or lipids and aldose sugars (Singh et al., 2001) characterized by fluorescence, brown color, and intra- and inter-molecular cross-linking and are formed by the process of nonenzymatic glycation, in which reducing sugars…”
BackgroundPereira, E. N. G. D. S., Silvares, R. R., Flores, E. E. I., Rodrigues, K. L., Ramos, I. P., da Silva, I. J., Pelajo‐Machado, M., Miranda, R. A., Pazos-Moura, C. C., Gonçalves-de-Albuquerque, C. F., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179654 · Cited by 69
Association of advanced glycation end products with sarcopenia and frailty in chronic kidney disease
Yabuuchi, J., Ueda, S., Yamagishi, S., Nohara, N., Nagasawa, H., Wakabayashi, K., Matsui, T., Higashimoto, Y., Kadoguchi, T., Otsuka, T., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-74673-x · Cited by 68
Akagawa, M., Sasaki, T., & Suyama, K. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.03243.x · Cited by 69
Transferrin Modifications and Lipid Peroxidation: Implications in Diabetes Mellitus
Campenhout, A. V., Campenhout, C. M. V., Lagrou, A., & Manuel‐y‐Keenoy, B. (2003) · Free Radical Research · doi:10.1080/10715760310001600390 · Cited by 75
“Their determination could thus give additional information and lead to an improved metabolic follow-up of diabetic patients([55]) The duration of the pre-incubations with glucose in our study (14 days) suggests that early or intermediate glycation (here measured as fructosamine) might be responsible.([47]) Detailed an…”
BackgroundHigai, K., Shimamura, A., & Matsumoto, K. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.12.008 · Cited by 67
Acute-phase proteins among patients with type 1 diabetes
Gomes, M. B., Piccirillo, L. J., Nogueira, V., & Matos, H. J. D. (2003) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70051-4 · Cited by 75
Quan, W., Zeng, M., Ye, J., Li, Y., Xue, C., Liu, G., Wang, Z., Qin, F., He, Z., & Chen, J. (2020) · Advances in Nutrition · doi:10.1093/advances/nmaa184 · Cited by 69
“Recently, there has been accumulating evidence showing that the consumption of dietary AGEs affected insulin signal and is related to the development of IR and type 2 diabetes (56, 57) because the AGEs promote oxidative stress and inflammation.”
BackgroundGlycation, carbonyl stress and AGEs inhibitors: a patent review
Jahan, H., & Choudhary, M. I. (2015) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2015.1076394 · Cited by 74
New developments in diabetic neuropathy
Sullivan, K. A., & Feldman, E. L. (2005) · Current Opinion in Neurology · doi:10.1097/01.wco.0000178825.56414.52 · Cited by 67
Ma, H., Liu, W., Frost, L., Kirschenbaum, L. J., Dain, J. A., & Seeram, N. P. (2016) · Food & Function · doi:10.1039/c6fo00169f · Cited by 67
Hollenbach, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112466 · Cited by 69
“Other, non-MGO-, non-GO-derived AGEs are pyrraline, 3-deoxyglucasone-lysine-dimer, and pentosidine [50].”
BackgroundDietary G-rutin suppresses glycation in tissue proteins of streptozotocin-induced diabetic rats
Nagasawa, T., Tabata, N., Ito, Y., Aiba, Y., NISHIZAWA, N., & Kitts, D. D. (2003) · Molecular and Cellular Biochemistry · doi:10.1023/a:1025563519088 · Cited by 72
“Accumulation of AGE is closely related with the production of reactive oxygen species (ROS) [15, 16], which can contribute to increased oxidative stress and cellular dysfunction [11].”
Biochemical Pathways for Microvascular Complications of Diabetes Mellitus
Setter, S. M., Campbell, R. K., & Cahoon, C. J. (2003) · Annals of Pharmacotherapy · doi:10.1345/aph.1d002 · Cited by 78
Lappas, M., Permezel, M., & Rice, G. E. (2007) · Journal of Endocrinology · doi:10.1677/joe-06-0081 · Cited by 69
“…that advanced glycation endproducts (AGE), which accumulate in diverse biological settings such as diabetes, aging and inflammation, exhibit immunomodulatory functions and therefore may be involved inmany normal and abnormal physiological processes (Singh et al. 2001, Ramasamy et al. 2005).”
BackgroundThe p38MAPK-MK2 Signaling Axis as a Critical Link Between Inflammation and Synaptic Transmission
Beamer, E. H., & Corrêa, S. A. L. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.635636 · Cited by 69
Balakumar, P., Arora, M. K., Ganti, S. S., Reddy, J., & Singh, M. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.02.002 · Cited by 74
Advanced glycation end products augment experimental hepatic fibrosis
Goodwin, M., Herath, C., Jia, Z., Leung, C., Coughlan, M. T., Forbes, J., & Angus, P. (2013) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12042 · Cited by 65
Watson, A. M. D., Gray, S. P., Jiaze, L., Soro-Paavonen, A., Wong, B., Cooper, M. E., Bierhaus, A., Pickering, R., Tikellis, C., Tsorotes, D., et al. (2012) · Diabetes · doi:10.2337/db11-1546 · Cited by 64
“Certainly, post-translational modification of amino, guanidino, and thiol functional groups on vulnerable proteins, lipids, and DNA targets has the potential to alter their structure, stability, and/or function (31,32).”
BackgroundBeta-Thalassemia Major and Female Fertility: The Role of Iron and Iron-Induced Oxidative Stress
Roussou, P. A., Tsagarakis, N. J., Kountouras, D., Livadas, S., & Diamanti‐Kandarakis, E. (2013) · Anemia · doi:10.1155/2013/617204 · Cited by 71
D’Silva, L. J., Staecker, H., Lin, Y.-C., Sykes, K. J., Phadnis, M. A., McMahon, T. M., Connolly, D., Sabus, C. H., Whitney, S. L., & Kluding, P. M. (2015) · Journal of Vestibular Research · doi:10.3233/ves-150563 · Cited by 68
“Formation of advanced glycation end products through the polyol pathway increases formation of ROS [29], which further depletes nitric oxide.”
Son, S., Hwang, I., Han, S. H., Shin, J.-S., Shin, O. S., & Yu, J.-W. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.806307 · Cited by 63
“Advanced glycation end products (AGEs)(2) belong to a group of heterogeneous compounds formed by non-enzymatic glycation of proteins (1).”
BackgroundThe importance of BDNF and RAGE in diabetes-induced dementia
Kim, O. Y., & Song, J. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105083 · Cited by 65
Nicolaou, I., & Demopoulos, V. J. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm0209477 · Cited by 70
Two Flavone C-Glycosides from the Style of Zea mays with Glycation Inhibitory Activity
Suzuki, R., Okada, Y., & Okuyama, T. (2003) · Journal of Natural Products · doi:10.1021/np020256d · Cited by 65
Diabetic vascular dysfunction: Links to glucose‐induced reductive stress and VEGF
Tilton, R. G. (2002) · Microscopy Research and Technique · doi:10.1002/jemt.10092 · Cited by 69
“…1999), increased formation of glucose-derived advanced glycation end products (Brownlee et al., 1988; Brownlee, 1995; Bucala and Vlassara, 1995; Singh et al., 2001; Vlassara et al., 1992), and glucose-induced activation of protein kinase C (Craven and De Rubertis, 1989; Koya and King, 1998;…”
Tauc, M., Cougnon, M., Carcy, R., Mélis, N., Hauet, T., Pellerin, L., Blondeau, N., & Pisani, D. F. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00733-y · Cited by 66
“This is important when considering the new concept [91] of chromatin remodelling depending, among others aspects, on the level of electrophilic metabolites produced in pathways such as acyl-CoA synthesis [92], lipid degradation [93], and glycolysis [94].”
BackgroundLee, Y. I., Lee, S. G., Jung, I., Suk, J., Lee, M., Kim, D.-U., & Lee, J. H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031101 · Cited by 68
“Previous studies have shown that the production of AGEs results in the activation of nuclear factor-kappa beta (NF-κB) transcription factors via the generation of oxygen radicals and MAP kinase signaling; the NF-κB activation subsequently leads to the induction of MMPs and formation of various proinflammatory cytokine…”
BackgroundShu, M., Cheng, W., Jia, X., Bai, X., Zhao, Y., Lu, Y., Zhu, L., Zhu, Y. S., Wang, L., Shu, Y., et al. (2023) · Molecular Medicine · doi:10.1186/s10020-023-00715-5 · Cited by 72
“Advanced glycation end products (AGEs) are the end products of non-enzymatic glycosylation of proteins, lipids, and nucleic acids with glucose and other reducing sugars (Singh et al. 2001).”
BackgroundDiabetes exacerbates amyloid and neurovascular pathology in aging‐accelerated mice
Currais, A. J. M., Prior, M., Lo, D., Jolivalt, C. G., Schubert, D. A., & Maher, P. A. (2012) · Aging Cell · doi:10.1111/acel.12002 · Cited by 73
“Advanced glycation end-products can activate both inflammatory and oxidative stress pathways (Singh et al., 2001), which have been linked to both aging and cerebrovascular disease (Srikanth et al., 2011).”
BackgroundInfluentialAdvanced glycation end products in degenerative nucleus pulposus with diabetes
Tsai, T., Ho, N. Y., Lin, Y., Lai, P., Fu, T., Niu, C., Chen, L., Chen, W., & Pang, J. S. (2013) · Journal of Orthopaedic Research® · doi:10.1002/jor.22508 · Cited by 64
“Advanced glycation occurs over a period of weeks, thereby proteins affected by covalent cross-link formation are stable and long lived, such as collagen.(19) Under diabetic conditions, AGEs accumulates abnormally in various tissues and organs, which can contribute to a gradual decline in tissue function and lead to th…”
BackgroundMetformin prevents methylglyoxal-induced apoptosis of mouse Schwann cells
Ota, K., Nakamura, J., Li, W., Kozakae, M., Watarai, A., Nakamura, N., Yasuda, Y., Nakashima, E., Naruse, K., Watabe, K., et al. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.03.140 · Cited by 67
He, J., Zeng, M., Zheng, Z., He, Z., & Chen, J. (2013) · European Food Research and Technology · doi:10.1007/s00217-013-2085-8 · Cited by 64
“Advanced glycation end products (AGEs) constitute a group of heterogeneous compounds formed by Maillard reaction (MR), a non-enzymatic reaction between reducing sugars and proteins, amino acids, or nucleic acids [1, 2].”
BackgroundTeodorowicz, M., Hendriks, W. H., Wichers, H. J., & Savelkoul, H. F. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02088 · Cited by 65
Walter, K. R., Ford, M. E., Gregoski, M. J., Kramer, R. M., Knight, K. D., Spruill, L., Nogueira, L. M., Krisanits, B. A., Phan, V. T., LaRue, A. C., et al. (2018) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-4992-7 · Cited by 67
Sell, D. R., & Monnier, V. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408946200 · Cited by 64
Mastrocola, R., Collino, M., Rogazzo, M., Medana, C., Nigro, D., Boccuzzi, G., & Aragno, M. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00450.2012 · Cited by 63
“Additionally, glucose is known to form AGE -oxoaldehydes, including GOLD (glyoxal-lysine dimer) and MOLD (methylglyoxal-lysine dimer), through the polyol pathway (41).”
Backgroundvan Dongen, K. C. W., Kappetein, L., Estruch, I. M., Belzer, C., Beekmann, K., & Rietjens, I. M. C. M. (2022) · Food and Chemical Toxicology · doi:10.1016/j.fct.2022.112987 · Cited by 65
Enteghad, S., Shirban, F., Nikbakht, M. H., Bagherniya, M., & Sahebkar, A. (2024) · International Dental Journal · doi:10.1016/j.identj.2024.03.010 · Cited by 77
“62 Moreover, AGEs-RAGEs interactions trigger the production of matrix metalloproteinases (MMPs) endopeptidases with a vital role in the extracellular matrix’s degradation, turnover, and remodelling.”
BackgroundHumoral methylglyoxal level reflects glycemic fluctuation
Nemet, I., Turk, Z., Duvnjak, L. S., Car, N., & Varga‐Defterdarovič, L. (2005) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2004.12.008 · Cited by 63
Accumulation of advanced glycation end-products in human dentine
Miura, J., Nishikawa, K., Kubo, M., FUKUSHIMA, S., Hashimoto, M., Takeshige, F., & Araki, T. (2013) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2013.10.012 · Cited by 70
WANG, X., CHANG, T., JIANG, B., Desai, K. M., & Wu, L. (2007) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2006.12.003 · Cited by 63
DNA damage in non-communicable diseases: A clinical and epidemiological perspective
Milić, M., Frustaci, A., Bufalo, A. D., Sánchez-Alarcón, J., Quintana, R. V., Russo, P., & Bonassi, S. (2014) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2014.11.009 · Cited by 63
Inhibition of advanced glycation end-product formation on eye lens protein by rutin
Muthenna, P., Akileshwari, C., Saraswat, M., & Bhanuprakash Reddy, G. (2012) · British Journal of Nutrition · doi:10.1017/s0007114511004077 · Cited by 64
“Amadori products, over a period of time, undergo a series of reactions involving multiple dehydration, fragmentation and oxidative modifications through highly reactive dicarbonyl intermediates to form stable, heterogeneous adducts called advanced glycation end products (AGE) (1–3) .”
Qais, F. A., Sarwar, T., Ahmad, I., Khan, R. A., Shahzad, S. A., & Husain, F. M. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.12.096 · Cited by 64
Soluble receptor for advanced glycation end products and risk of liver cancer
Moy, K. A., Jiao, L., Freedman, N. D., Weinstein, S. J., Sinha, R., Virtamo, J. R. K., Albanes, D., & Stolzenberg‐Solomon, R. Z. (2013) · Hepatology · doi:10.1002/hep.26264 · Cited by 65
“Supported by the Intramural Research Program of the National Institutes of Health, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD. 2338 AGEs up-regulate inflammation by binding their fulllength membrane-bound…”
BackgroundInfluentialMir, A. R., Uddin, M., Alam, K., & Ali, A. (2014) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2014.05.057 · Cited by 62
Rehmannia glutinosa Suppresses Inflammatory Responses Elicited by Advanced Glycation End Products
Baek, G. M. W. S. G., Jang, Y., Jeong, S.-I., Cha, J., Joo, M., Shin, S.-W., Ha, K., & Jeong, H.-S. (2012) · Inflammation · doi:10.1007/s10753-012-9433-x · Cited by 67
“The occurrence of these diabetic complications is closely associated with the presence of advanced glycation end products (AGEs), along with disturbances in polyol pathway and the activation of protein kinase C [2, 3].”
BackgroundEffects of diabetes mellitus vs.in vitrohyperglycemia on select immune cell functions
Daoud, A. K., Tayyar, M. A., Fouda, I. M., & Abuharfeil, N. M. (2009) · Journal of Immunotoxicology · doi:10.1080/15476910802604564 · Cited by 62
“Different models and explanations have been proposed, including cell surface protein glycosylation (especially surface receptors), effects of glycation end-products, and increased glycosylation of proteins and/or enzymes that leads to cellular inhibition (Sensi et al., 1991; Singh et al., 2001).”
BackgroundInhibitors of Advanced Glycation End Product (AGE) Formation and Accumulation
Sourris, K. C., Watson, A. M. D., & Jandeleit-Dahm, K. A. M. (2020) · Handbook of experimental pharmacology · doi:10.1007/164_2020_391 · Cited by 66
Wang, X., Desai, K. M., Juurlink, B. H. J., de Champlain, J., & Wu, L. (2006) · Kidney International · doi:10.1038/sj.ki.5000043 · Cited by 62
Ashraf, J. M., Ahmad, S., Rabbani, G., Hasan, Q., Jan, A. T., Lee, E. J., Khan, R. H., Alam, K., & Choi, I. (2015) · PLoS ONE · doi:10.1371/journal.pone.0116804 · Cited by 61
“Advanced glycation end products (AGEs) results in the non-enzymatic modifications of biological macromolecules by reducing sugars [1].”
BackgroundProtein glycation inhibitory activity and antioxidant capacity of clove extract
Suantawee, T., Wesarachanon, K., Anantsuphasak, K., Daenphetploy, T., Thien-Ngern, S., Thilavech, T., Pasukamonset, P., Ngamukote, S., & Adisakwattana, S. (2014) · Journal of Food Science and Technology · doi:10.1007/s13197-014-1452-1 · Cited by 71
“It is well established that the initial Schiff's base undergoes repeated condensation and rearrangement to form a relatively stable Amadori product, which induces further oxidative modifications to generate advanced glycation end products (AGEs), including cross-linking fluorescent adducts (pentosidine) and non-fluore…”
BackgroundLeslie, R. D., & Cohen, R. M. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300403 · Cited by 67
Tomino, Y. (2012) · Nephro-Urology Monthly · doi:10.5812/numonthly.1954 · Cited by 61
“The presence of AGEs is closely related to hyperglycemia and their pathobiochemistry could explain diabetic nephropathy (12).”
Therapy Insight: sexual and bladder dysfunction associated with diabetes mellitus
Fedele, D. (2005) · Nature Clinical Practice Urology · doi:10.1038/ncpuro0211 · Cited by 61
Xu, D., & Kyriakis, J. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302771200 · Cited by 64
Metadata
- Authors
- Singh, R., Barden, A., Mori, T., & Beilin, L.
- Affiliations
- The University of Western Australia (AU)
- Venue
- Diabetologia
- Published
- 2001-02-05
- Volume
- 44
- Issue
- 2
- Pages
- 129-146
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W1966234811
- Cited by
- 2,597
- References
- 45
- Citations by year
- 2026: 67 · 2025: 85 · 2024: 124 · 2023: 117 · 2022: 152 · 2021: 161 · 2020: 138 · 2019: 142 · 2018: 118 · 2017: 118 · 2016: 130 · 2015: 139 · 2014: 132 · 2013: 114 · 2012: 132
- FWCI
- 36.26
- Type
- journal article
- Language
- en
- Update notices
- correction (2014-04-30)
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- Funders
- Medical Research Council
- National Health and Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Keywords
- advanced glycation end products, diabetes complications, diabetic microvascular complications, diabetic retinopathy, diabetic neuropathy, diabetic nephropathy, diabetic vascular disease, carbonyl stress, aminoguanidine
- MeSH terms
- Receptor for Advanced Glycation End Products, Aging, Diabetes Mellitus, Diabetic Nephropathies, Diabetic Neuropathies, Diabetic Retinopathy, Food, Humans, Plants, Toxic, Receptors, Immunologic, Nicotiana, Glycation End Products, Advanced
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.